This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cao, Y.-a. Articles by Band, V. Search for Related Content PubMed Articles by Cao, Y.-a. Articles by Band, V.

Abrogation of Wild-type p53-mediated Transactivation is Insufficient for Mutant p53-induced Immortalization of Normal Human Mammary Epithelial Cells¹

Department of Radiation Oncology, Division of Radiation and Cancer Biology, New England Medical Center [Y-A. C., Q. G., D. E. W., V. B.], and Department of Biochemistry, Tufts University School of Medicine [V. B.], Boston, Massachusetts 02111

The p53 protein has become a subject of intense interest since the discovery that about 50% of human cancers carry p53 mutations. Mutations in the p53 gene are the most frequent genetic lesions in breast cancer, suggesting a critical role for p53 protein in normal mammary epithelial cell (MEC) growth control. We previously demonstrated that abrogation of the p53 function by a cancer-derived p53 mutant, del239, was sufficient to induce immortalization of normal MECs. To further extend these findings and to examine the mechanism of mutant p53-induced immortalization of MECs, we tested the immortalizing ability of four selected p53 mutants (R175H, R248W, R249S, and R273H), which involve residues that cluster close to N239 in the three-dimensional structure and which are critical for the DNA-binding function of p53. Interestingly, two of these mutants (R175H and R249S) reproducibly immortalized 76N normal MECs, whereas the other two mutants (R248W and R273H) induced an extension of life span but not immortalization. These results further substantiate that selective ablation of p53 function with dominant-negative mutants is sufficient for immortalization of MECs. To determine whether abrogation of the transactivation function of endogenous p53 was important for the differential immortalizing ability of p53 mutants, we measured the effects of mutant p53 on the endogenous wild-type p53-mediated transactivation of a chloramphenicol acetyltransferase reporter linked to a consensus p53 binding DNA sequence in transiently transfected 76N MECs. All of the mutants, regardless of their immortalizing phenotype, abrogated the endogenous wild-type p53-mediated transactivation to a similar extent. Thus, abrogation of transactivation function is not sufficient for mutant p53-induced immortalization of normal MECs. The p53-immortalized MECs showed substantial telomerase activity; however, induction of telomerase activity occurred at late passages and was undetectable in mutant p53-expressing cells prior to immortalization. We suggest that mechanisms other than abrogation of transactivation and induction of telomerase activity determine the differential MEC-immortalizing behavior of various p53 mutants.

¹ This work was supported by NIH Grants CA56803 and CA64823 and the Geyer Foundation (to V. B.).

² The first two authors contributed equally to this work.

³ To whom requests for reprints should be addressed, at Department of Radiation Oncology, Division of Radiation and Cancer Biology, New England Medical Center, 750 Washington Street, Boston, MA 02111. Phone: (617) 636-4776; Fax: (617) 636-6205; E-mail: vband@opal.tufts.edu.

Received 6/20/97. Accepted 10/15/97.

This article has been cited by other articles:

				X. Zhao, L. Lu, N. Pokhriyal, H. Ma, L. Duan, S. Lin, N. Jafari, H. Band, and V. Band Overexpression of RhoA Induces Preneoplastic Transformation of Primary Mammary Epithelial Cells Cancer Res., January 15, 2009; 69(2): 483 - 491. [Abstract] [Full Text] [PDF]

				X. Zhao, M. Goswami, N. Pokhriyal, H. Ma, H. Du, J. Yao, T. A. Victor, K. Polyak, C. D. Sturgis, H. Band, et al. Cyclooxygenase-2 Expression during Immortalization and Breast Cancer Progression Cancer Res., January 15, 2008; 68(2): 467 - 475. [Abstract] [Full Text] [PDF]

				A. C. Blackburn, L. Z. Hill, A. L. Roberts, J. Wang, D. Aud, J. Jung, T. Nikolcheva, J. Allard, G. Peltz, C. N. Otis, et al. Genetic Mapping in Mice Identifies DMBT1 as a Candidate Modifier of Mammary Tumors and Breast Cancer Risk Am. J. Pathol., June 1, 2007; 170(6): 2030 - 2041. [Abstract] [Full Text] [PDF]

				D. Dornan, S. Bheddah, K. Newton, W. Ince, G. D. Frantz, P. Dowd, H. Koeppen, V. M. Dixit, and D. M. French COP1, the Negative Regulator of p53, Is Overexpressed in Breast and Ovarian Adenocarcinomas Cancer Res., October 15, 2004; 64(20): 7226 - 7230. [Abstract] [Full Text] [PDF]

				V. A. Shamanin and E. J. Androphy Immortalization of Human Mammary Epithelial Cells Is Associated with Inactivation of the p14ARF-p53 Pathway Mol. Cell. Biol., March 1, 2004; 24(5): 2144 - 2152. [Abstract] [Full Text] [PDF]

				G. P. Dimri, J.-L. Martinez, J. J. L. Jacobs, P. Keblusek, K. Itahana, M. van Lohuizen, J. Campisi, D. E. Wazer, and V. Band The Bmi-1 Oncogene Induces Telomerase Activity and Immortalizes Human Mammary Epithelial Cells Cancer Res., August 15, 2002; 62(16): 4736 - 4745. [Abstract] [Full Text] [PDF]

				Y. Maniwa, M. Yoshimura, C. Obayashi, M. Inaba, K. Kiyooka, M. Kanki, and Y. Okita Association of p53 Gene Mutation and Telomerase Activity in Resectable Non-Small Cell Lung Cancer Chest, August 1, 2001; 120(2): 589 - 594. [Abstract] [Full Text] [PDF]

				A. Sigal and V. Rotter Oncogenic Mutations of the p53 Tumor Suppressor: The Demons of the Guardian of the Genome Cancer Res., December 1, 2000; 60(24): 6788 - 6793. [Abstract] [Full Text]

				O. Gjoerup, H. Chao, J. A. DeCaprio, and T. M. Roberts pRB-Dependent, J Domain-Independent Function of Simian Virus 40 Large T Antigen in Override of p53 Growth Suppression J. Virol., January 1, 2000; 74(2): 864 - 874. [Abstract] [Full Text]

				Y. Liu, J. J. Chen, Q. Gao, S. Dalal, Y. Hong, C. P. Mansur, V. Band, and E. J. Androphy Multiple Functions of Human Papillomavirus Type 16 E6 Contribute to the Immortalization of Mammary Epithelial Cells J. Virol., September 1, 1999; 73(9): 7297 - 7307. [Abstract] [Full Text]

				Q. Gao, S. Srinivasan, S. N. Boyer, D. E. Wazer, and V. Band The E6 Oncoproteins of High-Risk Papillomaviruses Bind to a Novel Putative GAP Protein, E6TP1, and Target It for Degradation Mol. Cell. Biol., January 1, 1999; 19(1): 733 - 744. [Abstract] [Full Text] [PDF]

				H.-F. Ding, G. McGill, S. Rowan, C. Schmaltz, A. Shimamura, and D. E. Fisher Oncogene-dependent Regulation of Caspase Activation by p53 Protein in a Cell-free System J. Biol. Chem., October 23, 1998; 273(43): 28378 - 28383. [Abstract] [Full Text] [PDF]